Hematogenix
Shuntae Williams, PhD, MSRS has extensive work experience in the field of scientific and regulatory affairs. Shuntae is currently the Scientific and Regulatory Affairs Director at Hematogenix, a position they have held since June 2021. Prior to this role, they served as the Associate Director of Biomarker Discovery & Development from December 2019 to the present. Shuntae also worked as a Senior Scientist at Hematogenix from June 2015 to December 2019.
Before joining Hematogenix, Shuntae worked as the Scientific and Technical Sales Manager at SeraCare Life Sciences from June 2013 until March 2015. Shuntae then worked at Ventana Medical Systems as a Key Account Technical Specialist from January 2009 to June 2013.
Shuntae's earlier work experience includes a position as a Post Doctoral Associate at the University of Alabama at Birmingham-Department of Microbiology/Immunology from August 2007 to January 2009.
Overall, Shuntae Williams has a diverse background in scientific and regulatory affairs, with experience in biomarker discovery, sales management, technical support, and academic research.
Shuntae Williams, PhD, MSRS obtained their Bachelor of Science in Chemistry from Tennessee State University in 2000. Shuntae then went on to earn their Doctor of Philosophy (PhD) in Microbiology from Meharry Medical College between 2000 and 2007. Finally, they completed their Master of Science (MS) in Regulatory Science at the Johns Hopkins University - Krieger School of Arts & Sciences from 2017 to 2019.
Hematogenix
1 followers
Hematogenix, a global cancer-focused life science company serving the pharmaceutical & biotechnology industry as well as community physicians. With passionate scientists and board-certified clinical and anatomic pathologists and hematopathologists from around the world, Hematogenix offers an array of biomarker development and testing services navigating the complexities of human diseases and clinical trials. Our global team of scientists provides reference laboratory services at our facilities around the globe: in the US, Europe, China, and Asia-Pacific. We are uniquely equipped to help clients accelerate cancer research and drug development efforts at these globally connected facilities. Hematogenix provides a complete menu of services such as Flow Cytometry, Molecular Genetics, Next Generation Sequencing (NGS), Histology / Immunohistochemistry (IHC), Cytogenetics / FISH, Pathology, Digital Pathology and Image Analysis. Our test menu reflects our commitment to utilizing the most advanced techniques to enhance patient care. We provide customized services ranging from the initial stages of research to development, and extending all the way to the implementation of targeted therapies in the clinical setting. * CAP – Accredited * CLIA – Certified * GCP – Compliant